A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients’ Characteristics, Comorbidity Profiles and Treatment Patterns

<i>Background and Objectives</i>: HCV infection represents a main risk factor for type 2 diabetes (T2D). This real-world analysis investigated the HCV-positive (HCV+) population with a T2D co-diagnosis in Italy. <i>Methods</i>: From 2017 to 2021, HCV+ patients were identified...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Edoardo Giovanni Giannini, Alessandra Mangia, Filomena Morisco, Pierluigi Toniutto, Angelo Avogaro, Stefano Fagiuoli, Claudio Borghi, Francesca Frigerio, Marta Nugnes, Chiara Veronesi, Maria Cappuccilli, Margherita Andretta, Marcello Bacca, Antonella Barbieri, Fausto Bartolini, Gianmarco Chinellato, Andrea Ciaccia, Renato Lombardi, Daniela Mancini, Romina Pagliaro, Loredana Ubertazzo, Luca Degli Esposti, Francesca Romana Ponziani
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Subjects:	antiviral therapies direct-acting antivirals hepatitis C virus pangenotypic direct-acting antivirals real-world evidence type 2 diabetes
Online Access:	https://www.mdpi.com/1648-9144/61/4/614